Top Markets
Coin of the day
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
Rank in Stocks #40860
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Share Price
$0.00312742
Last synced: 2024-10-01
Market Cap
$70.81K
Change (1 day)
-21.83%
Change (1 year)
0.00%
Country
SE
Trade Asarina Pharma AB (publ) (ASAP)

Category

P/E ratio for Asarina Pharma AB (publ) (ASAP)
P/E ratio as of August 2026 TTM: -0.05
According to Asarina Pharma AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.05. At the end of 2022 the company had a P/E ratio of -1.31.
P/E ratio history for Asarina Pharma AB (publ) from 2017 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -0.05 -96.83%
2023 -1.55 18.20%
2022 -1.31 14.51%
2021 -1.15 -23.56%
2020 -1.50 -73.67%
2019 -5.70 -36.12%
2018 -8.92 -4.75%
2017 -9.37 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
28.05 -57,224.64%
US
31.14 -63,530.14%
NL
- -
CH
- -
KR
19.30 -39,404.89%
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.